News and events

04.12.2008 Montpellier Prostate Cancer Patient Becomes First Cancer Patient In France Treated With Varian's RapidArcÁ Radiotherapy

A 60-year-old prostate cancer patient from Montpellier has become the first person in France to be treated using RapidArcÁ technology from Varian M... read more

03.12.2008 PharmaEngine Receives Approval Of US IND Application For A Phase II Study Of PEP02 (Liposome Irinotecan Injection) In Pancreatic Cancer

PharmaEngine, Inc. announced today that it has received approval of an Investigational New Drug (IND) application from the U.S. FDA for PEP02, a lipos... read more

02.12.2008 Diamyd Medical: Diamyd(R) Diabetes Vaccine - Three Blockbuster Indications

As reported in New England Journal of Medicine (Oct 30, 2008), Diamydᢠpreserves insulin producing beta cells best in patients recently diagnosed wit... read more

02.12.2008 Harnessing MiRNA Natural Gene Repressors For Anticancer Therapy

Michel Sadelain and colleagues, at Memorial Sloan-Kettering Cancer Center, New York, have developed a new approach to modulate the expression of gen... read more

01.12.2008 Marshall Edwards, Inc. Files IND Application For Triphendiol - Locally Advanced Or Metastatic Pancreatic And Bile Duct Cancers

Marshall Edwards, Inc. (NASDAQ: MSHL) today announced that it has filed an application with the United States Food and Drug Administration fo... read more

30.11.2008 A Class Of Small RNAs Inherited From The Mother Determines Offspring's Fertility Trait

Hereditary information flows from parents to offspring not just through DNA but also through the millions of proteins and other molecules that cling t... read more

29.11.2008 Stem Cell Obstacles

"There are still a number of major hurdles in the path of stem cell research today that are preventing the routine application of the technology in re... read more

29.11.2008 Insight Into Adaptive Ability Of Cells Offered By Rong Li Lab

The Stowers Institute's Rong Li Lab has published findings that shed light on the ability of cells to adapt to disruptions to their basic division ma... read more

28.11.2008 Exonhit Launches Mouse Genome Splicearraytm For Use In Human Disease Modeling Studies

ExonHit Therapeutics S.A. (Alternext: ALEHT), a drug and diagnostic discovery company, announces today the availability of its new SpliceArrayÁ fo... read more

28.11.2008 Most Brits Want To Die At Home While The Majority Are Dying In Hospital

A report by The Audit Office informs that most people in the United Kingdom are dying in hospital - even though the majority would prefer to die at ... read more

Ñòðàíèöà 25 èç 100

< Previous 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100 Next >